Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Pen Needles Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Pen Needles Companies Quadrant is a comprehensive ...

The new line of insulin pen needles is said to provide healthcare professionals with a range of needle gauges and sizes. Credit: JFontan / Shutterstock.com. Trividia Health UK has launched the ...

[Image courtesy of Trividia Health] Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK. The new five-bevel pen needle provides healthcare ...

For people with diabetes who inject insulin, the syringe and needle size can make a big difference in comfort and staying on track with steady blood sugar levels. According to a 2024 statistics report ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics. By Katie Thomas Maricruz Salgado was bringing her ...

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities. “To address our current capacity ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...

Please provide your email address to receive an email when new articles are posted on . A U.S. hospital reduced insulin pen waste by 18.3% after bolstering education efforts and medical alerts. Costs ...

Insulin therapy is essential for managing diabetes. It includes various methods such as basal-bolus, fixed-dose, pump, pen, and inhaler therapies. These therapies help control blood sugar levels, ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Diabetes device maker Embecta has hired advisers to explore a possible sale, following two years of ...